Search research articles
Contact Us
Filters
Showing results (931-940 of 1,180) with videos related to
Page
of 118
Sort By:
Physical Review Letters
|
May 1, 2012
Electric-field control of nonvolatile magnetization in Co40Fe40B20/Pb(Mg(1/3)Nb(2/3))(0.7)Ti(0.3)O3 structure at room temperature
S Zhang, Y G Zhao, P S Li, et al.
The Lancet. Oncology
|
October 17, 2016
Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis
Shuang G Zhao, S Laura Chang, Daniel E Spratt, et al.
Genome Biology
|
April 16, 2026
Convergent evolution of complex structural variants drives therapy resistance in metastatic prostate cancer
Thaidy Moreno-Rodriguez, Meng Zhang, Arian Lundberg, et al.
Biorxiv : the Preprint Server for Biology
|
June 12, 2025
OGDHL regulates nucleotide metabolism, tumor growth, and neuroendocrine marker expression in prostate cancer
Matthew J Bernard, Angel Ruiz, Johnny A Diaz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 20, 2023
Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer
Jamie M Sperger, Kyle T Helzer, Charlotte N Stahlfeld, et al.
Journal of the National Cancer Institute
|
October 16, 2018
The Immune Landscape of Prostate Cancer and Nomination of PD-L2 as a Potential Therapeutic Target
Shuang G Zhao, Jonathan Lehrer, S Laura Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 14, 2019
Transcriptomic Heterogeneity of Androgen Receptor Activity Defines a <i>de novo</i> low AR-Active Subclass in Treatment Naïve Primary Prostate Cancer
Daniel E Spratt, Mohammed Alshalalfa, Nick Fishbane, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
April 15, 2016
A multicentre, randomized, single-blind comparison of topical clindamycin 1%/benzoyl peroxide 5% once-daily gel versus clindamycin 1% twice-daily gel in the treatment of mild to moderate acne vulgaris in Chinese patients
J H Xu, Q J Lu, J H Huang, et al.
European Urology
|
December 11, 2020
Novel Transcriptomic Interactions Between Immune Content and Genomic Classifier Predict Lethal Outcomes in High-grade Prostate Cancer
Kosj Yamoah, Shivanshu Awasthi, Brandon A Mahal, et al.
JCI Insight
|
September 24, 2024
Clinical cell-surface targets in metastatic and primary solid cancers
Marina N Sharifi, Yue Shi, Matthew R Chrostek, et al.
Page
of 118
Search research articles
Search
Showing results (931-940 of 1,180) with videos related to
Sort By:
Page
of 118
Physical Review Letters
|
May 1, 2012
Electric-field control of nonvolatile magnetization in Co40Fe40B20/Pb(Mg(1/3)Nb(2/3))(0.7)Ti(0.3)O3 structure at room temperature
S Zhang, Y G Zhao, P S Li, et al.
The Lancet. Oncology
|
October 17, 2016
Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis
Shuang G Zhao, S Laura Chang, Daniel E Spratt, et al.
Genome Biology
|
April 16, 2026
Convergent evolution of complex structural variants drives therapy resistance in metastatic prostate cancer
Thaidy Moreno-Rodriguez, Meng Zhang, Arian Lundberg, et al.
Biorxiv : the Preprint Server for Biology
|
June 12, 2025
OGDHL regulates nucleotide metabolism, tumor growth, and neuroendocrine marker expression in prostate cancer
Matthew J Bernard, Angel Ruiz, Johnny A Diaz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 20, 2023
Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer
Jamie M Sperger, Kyle T Helzer, Charlotte N Stahlfeld, et al.
Journal of the National Cancer Institute
|
October 16, 2018
The Immune Landscape of Prostate Cancer and Nomination of PD-L2 as a Potential Therapeutic Target
Shuang G Zhao, Jonathan Lehrer, S Laura Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 14, 2019
Transcriptomic Heterogeneity of Androgen Receptor Activity Defines a <i>de novo</i> low AR-Active Subclass in Treatment Naïve Primary Prostate Cancer
Daniel E Spratt, Mohammed Alshalalfa, Nick Fishbane, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
April 15, 2016
A multicentre, randomized, single-blind comparison of topical clindamycin 1%/benzoyl peroxide 5% once-daily gel versus clindamycin 1% twice-daily gel in the treatment of mild to moderate acne vulgaris in Chinese patients
J H Xu, Q J Lu, J H Huang, et al.
European Urology
|
December 11, 2020
Novel Transcriptomic Interactions Between Immune Content and Genomic Classifier Predict Lethal Outcomes in High-grade Prostate Cancer
Kosj Yamoah, Shivanshu Awasthi, Brandon A Mahal, et al.
JCI Insight
|
September 24, 2024
Clinical cell-surface targets in metastatic and primary solid cancers
Marina N Sharifi, Yue Shi, Matthew R Chrostek, et al.
Page
of 118